Disparities Exist in Use of Obesity-Management Medications
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 2, 2025 -- Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online Dec. 17 in the Journal of Racial and Ethnic Health Disparities.
Kimberly Narain, M.D., M.P.H., Ph.D., from the University of California, Los Angeles, and Christopher Scannell, M.D., Ph.D., from the University of Southern California in Los Angeles, assessed racial and ethnic differences in the utilization of obesity-management medications among clinically eligible individuals. The analysis included data from the Medical Expenditure Panel Survey (2011 to 2016, 2018, and 2020) for adult participants with a body mass index ≥30 kg/m2 and individuals with a body mass index ≥27 kg/m2 with one or more weight-related conditions.
The researchers found that Asian (adjusted odds ratio, 0.36), Black (adjusted odds ratio, 0.51), and Hispanic individuals (adjusted odds ratio, 0.70) had significantly lower odds of utilizing obesity-management medications compared with White individuals. Among Black and Hispanic individuals, factors partially accounting for these disparities included lower levels of education, lack of health insurance, and higher levels of public health insurance.
"These findings call for the continued exploration of the utilization and perception toward the ever evolving and modernizing obesity medication market," the authors write. "Understanding the perceptions of all populations toward emerging and popularized treatment options is essential to minority health."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Helping Others Linked to Higher Level of Cognitive Function
THURSDAY, Aug. 21, 2025 -- Helping others, both via formal volunteering and informal helping, is associated with higher levels of cognitive function and slower cognitive decline...
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
THURSDAY, Aug. 21, 2025 -- For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC), an intravesical...
Work-Related Income Drops for Parents of Children Diagnosed With Type 1 Diabetes
THURSDAY, Aug. 21, 2025 -- Work-related income decreases sharply for mothers and fathers of children diagnosed with type 1 diabetes, with similar effects across sociodemographic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.